A note on scientific peer-review as regards the controversial @JAMAInternalMed study on #LongCovid
I submitted a rapid response, which JAMA declined to publish
In so doing, I stumbled upon a couple of key issues about how the review of papers published there works
These issues can help explain how the very controversial paper in question might have been published in a medical journal of good standing despite its obvious shortcomings and scientific inconsistencies
Long 🧵 with some technical comments about academic peer review
You, basically, submit your paper via an online platform. One key point is that you can list, in the system, a good number of reviewers of your choice by name. Reviewers are experts who will read your manuscript, and suggest the journal whether to publish it or not.
It's obvious that, at this stage, you will select people who have a scientific perspective similar to yours. It's not guaranteed, I guess, the journal will send your manuscript to review exactly to the people you suggested, but I presume this can happen!
You are also allowed, in the online system, to select "negative" reviewers i.e. people you don't want your manuscript being sent to. You will select at this point, obviously, researchers who have very different ideas from yourself! This is to minimize the risks of rejection
You can also select, in the online submission system, the specific section of the journal where you would like your paper to be published in. You may remember we discussed on Twitter that @JAMAInternalMed has a section called "Less is More". This section |
"Less is More" in JAMA focuses on ways to reduce the burden of patients and medical treatment for healthcare system. You bet you are allowed to select --- as you submit your paper online --- you want it to be considered for this specific section of the journal!
All in all, I think the very same way the submission system in JAMA Internal Medicine works, may allow some low-quality research to pass the external (outside of the journal) peer-review process, and get published --- despite this research being of poor quality in itself
I have to add that these are just my own reflections on the academic peer review system, with particular regard to this specific journal. I certainly can't prove or guarantee that the JAMA paper in question got published because of these issues with the peer review system
I do think, however, that the way science works nowadays --- can be conductive to the production of suboptimal research in some cases: gatekeeping, "friendships" among certain researchers, and the structure of peer review favour those who are well connected in the system
I add JAMA declined to publish because they had already received other scientific letters criticising the use of serology in the study, so there should be more debate on that soon! Hopefully! ⭐
• • •
Missing some Tweet in this thread? You can try to
force a refresh
I recommend reading this great thread about the long-lasting effects of SARS-CoV-2 infection
Again, this isn't news. We patient-researchers in the first wave had correctly, scientifically, defined covid as a multi-system and prolonged disease ---> #LongCovid
The narrative that covid was a respiratory disease, mild and short in the young, was wrong. It was blown away by patients in the early 2020, including in academic peer-reviewed pieces
I also suggest to read this great piece by physician-researcher @zalaly in the @guardian on the critical impact of #LongCovid patient-led advocacy and research in medicine
This is just news. Thus, not to be taken as a medical record. Notable if #Omicron | partial immune escape even in the vaccinated: two doses only, here, apparently | the possibility of relatively severe disease | presence of at least mild hypoxemia | deterioration days from onset
Overall, and in view of the caveats above = using informal and not official clinical records: #Omicron | covid are not a "cold" or a "little flu" even in those who are vaccinated. Please let's keep vigilant and use all the safety measures at our disposal like airborne prevention
The US is on a monstrous, largely unleashed SARS-CoV-2 spread.
Almost 2000 new deaths. Over 104.000 people in hospital. Almost 20.000 people in ICU. One million new official cases.
This is horrible and not "mild"
We know, scientifically many wil develop #LongCovid
Even if most of the new cases are indeed "mild" and not leading to prolonged disease in view of vaccination, some, at least, will. Maybe many. This is out of 1 million people
We know scientifically that most of those hospitalized or in ICU will develop long-term health issues
We could be facing a monstrous reality where at least 100.000 people --- just to provide a very crude estimate --- could be becoming chronically sick, ill with a prolonged disease, or permanently disabled *only today*. In a single country. From a single disease.
I stand again with @apresj20 and the other patient-led advocacy groups against poor research on #LongCovid, which has been, sadly, published even in a reputable medical journal like @JAMAInternalMed
We need only the top biomedical and patient-researchers to work on Long Covid
Unfortunately, we have seen a few very poor studies, such as the one recently published in @JAMAInternalMed, make it into medical journals with a good standing in the discipline. Such studies are led by psychiatrics or psychologists with no specific expertise on #LongCovid
#LongCovid, the funding made available to study it, and the paradigm shifts this pandemic is bringing about in medicine, are a once-in-a-generation opportunity to transform how we approach the spread of pathogens, post viral diseases, concepts of disability etc.
This is a key point about coagulopathy in #LongCovid and (I'd think maybe) a subset of acute covid too 💉
Many have normal ddmer levels because the ddmer is the degraded remnant of clots breaking down
The process of breaking clots down seems impaired in (some) in Long Covid
SARS-CoV-2 infection can lead to prolonged, multidimensional, potentially irreversible | degenerative brain 🧠 damage in both hospitalized and non-hospitalized covid patients 🔺️
[pre-print | extensive brain imaging from the UK biobank]
A significant strenght of the study is availability of brain 🧠 scans from the *same people* before and after SARS-CoV-2 infection
This allows to compare any changes to their brain across time, with pathological changes most likely caused by covid itself
The study used multimodal MRI 🧠 scan of over 700 people who were assessed before and after the covid emergency.
Of these scans, analysis of the 401 people who had tested positive for SARS-CoV-2 revealed multidimensional effects on the brain | different brain areas